Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial
IGC Pharma, Inc. reported additional interim data from its clinical trial evaluating IGC-AD1 for agitation in Alzheimer’s.
Medical Xpress7 天
How the body's own cannabinoids may influence the symptoms and treatment of ADHD
Nursing researcher Jennie Ryan, Ph.D., at Thomas Jefferson University, studies the effects of cannabis on symptoms of attention deficit hyperactivity disorder (ADHD). Current medical guidelines ...
Labroots10 天
Study Explore Cannabinoid CBN's Ability to Counter Sleep Disorders
A study published in Neuropsychopharmacology indicated that cannabinol (CBN) sleep-promoting properties comparable to conventional sleep medications. The f | Cannabis Sciences ...
Tucson Weekly11 天
Study: Cannabinol a promising sleep aid
[ { "name": "Air - MedRect Combo - Inline Content 1", "component": "29441156", "insertPoint": "1/3", "requiredCountToDisplay": "9", "parentWrapperClass": "fdn-ads ...